skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

New regulatory and drug pricing policies are negatively impacting growth in the Indian pharmaceutical sector, but opportunities remain.


Highlights in this whitepaper include:

  • The effect of tighter regulations on the number of clinical trials conducted in India
  • The impact of inadequate patent protection for branded players and domestic generic manufacturers
  • The challenges faced with compulsory licensing of patented drugs
  • The result the expanding pricing controls will have on the multinational companies
  • Cheap generic medicines vs. branded manufacturers
  • Opportunities and challenges for multinational companies
Indian Pharmaceutical Market

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or email us your inquiry, so we can provide you the best possible customer service:

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: